227 related articles for article (PubMed ID: 30586952)
1. Prognostic Impact of Fusobacterium nucleatum Depends on Combined Tumor Location and Microsatellite Instability Status in Stage II/III Colorectal Cancers Treated with Adjuvant Chemotherapy.
Oh HJ; Kim JH; Bae JM; Kim HJ; Cho NY; Kang GH
J Pathol Transl Med; 2019 Jan; 53(1):40-49. PubMed ID: 30586952
[TBL] [Abstract][Full Text] [Related]
2. Prognostic impact of the Fusobacterium nucleatum status in colorectal cancers.
Chen Y; Lu Y; Ke Y; Li Y
Medicine (Baltimore); 2019 Sep; 98(39):e17221. PubMed ID: 31574832
[TBL] [Abstract][Full Text] [Related]
3. Clinical Significance of
Xie Y; Jiao X; Zeng M; Fan Z; Li X; Yuan Y; Zhang Q; Xia Y
Cancer Manag Res; 2022; 14():3021-3036. PubMed ID: 36262751
[TBL] [Abstract][Full Text] [Related]
4. Association Between Fusobacterium nucleatum, Pathway Mutation, and Patient Prognosis in Colorectal Cancer.
Lee DW; Han SW; Kang JK; Bae JM; Kim HP; Won JK; Jeong SY; Park KJ; Kang GH; Kim TY
Ann Surg Oncol; 2018 Oct; 25(11):3389-3395. PubMed ID: 30062471
[TBL] [Abstract][Full Text] [Related]
5. Intratumoral Fusobacterium nucleatum abundance correlates with macrophage infiltration and CDKN2A methylation in microsatellite-unstable colorectal carcinoma.
Park HE; Kim JH; Cho NY; Lee HS; Kang GH
Virchows Arch; 2017 Sep; 471(3):329-336. PubMed ID: 28597080
[TBL] [Abstract][Full Text] [Related]
6.
Hamada T; Zhang X; Mima K; Bullman S; Sukawa Y; Nowak JA; Kosumi K; Masugi Y; Twombly TS; Cao Y; Song M; Liu L; da Silva A; Shi Y; Gu M; Li W; Koh H; Nosho K; Inamura K; Keum N; Wu K; Meyerhardt JA; Kostic AD; Huttenhower C; Garrett WS; Meyerson M; Giovannucci EL; Chan AT; Fuchs CS; Nishihara R; Giannakis M; Ogino S
Cancer Immunol Res; 2018 Nov; 6(11):1327-1336. PubMed ID: 30228205
[TBL] [Abstract][Full Text] [Related]
7. Association of Fusobacterium nucleatum with clinical and molecular features in colorectal serrated pathway.
Ito M; Kanno S; Nosho K; Sukawa Y; Mitsuhashi K; Kurihara H; Igarashi H; Takahashi T; Tachibana M; Takahashi H; Yoshii S; Takenouchi T; Hasegawa T; Okita K; Hirata K; Maruyama R; Suzuki H; Imai K; Yamamoto H; Shinomura Y
Int J Cancer; 2015 Sep; 137(6):1258-68. PubMed ID: 25703934
[TBL] [Abstract][Full Text] [Related]
8. Fusobacterium nucleatum load in MSI colorectal cancer subtypes.
Ono T; Yamaguchi T; Takao M; Kojika E; Iijima T; Horiguchi SI
Int J Clin Oncol; 2022 Oct; 27(10):1580-1588. PubMed ID: 35859218
[TBL] [Abstract][Full Text] [Related]
9. Differential immune microenvironmental features of microsatellite-unstable colorectal cancers according to Fusobacterium nucleatum status.
Lee JA; Yoo SY; Oh HJ; Jeong S; Cho NY; Kang GH; Kim JH
Cancer Immunol Immunother; 2021 Jan; 70(1):47-59. PubMed ID: 32623478
[TBL] [Abstract][Full Text] [Related]
10. Clinical impact of microsatellite instability in colon cancer following adjuvant FOLFOX therapy.
Kim ST; Lee J; Park SH; Park JO; Lim HY; Kang WK; Kim JY; Kim YH; Chang DK; Rhee PL; Kim DS; Yun H; Cho YB; Kim HC; Yun SH; Lee WY; Chun HK; Park YS
Cancer Chemother Pharmacol; 2010 Sep; 66(4):659-67. PubMed ID: 20033812
[TBL] [Abstract][Full Text] [Related]
11. Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis.
Mima K; Nishihara R; Qian ZR; Cao Y; Sukawa Y; Nowak JA; Yang J; Dou R; Masugi Y; Song M; Kostic AD; Giannakis M; Bullman S; Milner DA; Baba H; Giovannucci EL; Garraway LA; Freeman GJ; Dranoff G; Garrett WS; Huttenhower C; Meyerson M; Meyerhardt JA; Chan AT; Fuchs CS; Ogino S
Gut; 2016 Dec; 65(12):1973-1980. PubMed ID: 26311717
[TBL] [Abstract][Full Text] [Related]
12. Fusobacterium nucleatum in Colorectal Carcinoma Tissue According to Tumor Location.
Mima K; Cao Y; Chan AT; Qian ZR; Nowak JA; Masugi Y; Shi Y; Song M; da Silva A; Gu M; Li W; Hamada T; Kosumi K; Hanyuda A; Liu L; Kostic AD; Giannakis M; Bullman S; Brennan CA; Milner DA; Baba H; Garraway LA; Meyerhardt JA; Garrett WS; Huttenhower C; Meyerson M; Giovannucci EL; Fuchs CS; Nishihara R; Ogino S
Clin Transl Gastroenterol; 2016 Nov; 7(11):e200. PubMed ID: 27811909
[TBL] [Abstract][Full Text] [Related]
13. Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor-κB, and Up-regulating Expression of MicroRNA-21.
Yang Y; Weng W; Peng J; Hong L; Yang L; Toiyama Y; Gao R; Liu M; Yin M; Pan C; Li H; Guo B; Zhu Q; Wei Q; Moyer MP; Wang P; Cai S; Goel A; Qin H; Ma Y
Gastroenterology; 2017 Mar; 152(4):851-866.e24. PubMed ID: 27876571
[TBL] [Abstract][Full Text] [Related]
14. Is microsatellite instability really a good prognostic factor of colorectal cancer?
Shin US; Cho SS; Moon SM; Park SH; Jee SH; Jung EJ; Hwang DY
Ann Coloproctol; 2014 Feb; 30(1):28-34. PubMed ID: 24639968
[TBL] [Abstract][Full Text] [Related]
15. Association of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancer.
Nosho K; Sukawa Y; Adachi Y; Ito M; Mitsuhashi K; Kurihara H; Kanno S; Yamamoto I; Ishigami K; Igarashi H; Maruyama R; Imai K; Yamamoto H; Shinomura Y
World J Gastroenterol; 2016 Jan; 22(2):557-66. PubMed ID: 26811607
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological and prognostic significance of Fusobacterium nucleatum infection in colorectal cancer: a meta-analysis.
Huangfu SC; Zhang WB; Zhang HR; Li Y; Zhang YR; Nie JL; Chu XD; Chen CS; Jiang HP; Pan JH
J Cancer; 2021; 12(6):1583-1591. PubMed ID: 33613745
[No Abstract] [Full Text] [Related]
17. The Impact of Mismatch Repair Status in Colorectal Cancer on the Decision to Treat With Adjuvant Chemotherapy: An Australian Population-Based Multicenter Study.
He EY; Hawkins NJ; Mak G; Roncolato F; Goldstein D; Liauw W; Clingan P; Chin M; Ward RL
Oncologist; 2016 May; 21(5):618-25. PubMed ID: 27009937
[TBL] [Abstract][Full Text] [Related]
18. Pathologic Factors Associated with Prognosis after Adjuvant Chemotherapy in Stage II/III Microsatellite-Unstable Colorectal Cancers.
Kim JH; Bae JM; Oh HJ; Lee HS; Kang GH
J Pathol Transl Med; 2015 Mar; 49(2):118-28. PubMed ID: 26148739
[TBL] [Abstract][Full Text] [Related]
19. Fusobacterium nucleatum tumor DNA levels are associated with survival in colorectal cancer patients.
Kunzmann AT; Proença MA; Jordao HW; Jiraskova K; Schneiderova M; Levy M; Liska V; Buchler T; Vodickova L; Vymetalkova V; Silva AE; Vodicka P; Hughes DJ
Eur J Clin Microbiol Infect Dis; 2019 Oct; 38(10):1891-1899. PubMed ID: 31367996
[TBL] [Abstract][Full Text] [Related]
20. Intratumoral
Yamamura K; Izumi D; Kandimalla R; Sonohara F; Baba Y; Yoshida N; Kodera Y; Baba H; Goel A
Clin Cancer Res; 2019 Oct; 25(20):6170-6179. PubMed ID: 31358543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
